These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23317403)

  • 1. Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias.
    Kostapanos MS; Rizos EC; Papanas N; Maltezos E; Elisaf MS
    Curr Pharm Des; 2013; 19(17):3150-60. PubMed ID: 23317403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.
    Sahebkar A; Watts GF
    Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.
    Mera Y; Odani N; Kawai T; Hata T; Suzuki M; Hagiwara A; Katsushima T; Kakutani M
    J Pharmacol Exp Ther; 2011 Feb; 336(2):321-7. PubMed ID: 20974698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
    Borradaile NM; de Dreu LE; Barrett PH; Behrsin CD; Huff MW
    Biochemistry; 2003 Feb; 42(5):1283-91. PubMed ID: 12564931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of apolipoprotein B and triglyceride secretion in human hepatoma cells (HepG2).
    Haghpassand M; Wilder D; Moberly JB
    J Lipid Res; 1996 Jul; 37(7):1468-80. PubMed ID: 8827519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal transfer protein inhibition in humans.
    Cuchel M; Rader DJ
    Curr Opin Lipidol; 2013 Jun; 24(3):246-50. PubMed ID: 23594709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?
    Sahebkar A; Watts GF
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):559-67. PubMed ID: 23913122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small-molecule inhibitor of enterocytic microsomal triglyceride transfer protein, SLx-4090: biochemical, pharmacodynamic, pharmacokinetic, and safety profile.
    Kim E; Campbell S; Schueller O; Wong E; Cole B; Kuo J; Ellis J; Ferkany J; Sweetnam P
    J Pharmacol Exp Ther; 2011 Jun; 337(3):775-85. PubMed ID: 21406547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New lipid modulating drugs: the role of microsomal transport protein inhibitors.
    Rizzo M; Wierzbicki AS
    Curr Pharm Des; 2011; 17(9):943-9. PubMed ID: 21418029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The late addition of core lipids to nascent apolipoprotein B100, resulting in the assembly and secretion of triglyceride-rich lipoproteins, is independent of both microsomal triglyceride transfer protein activity and new triglyceride synthesis.
    Pan M; Liang Js JS; Fisher EA; Ginsberg HN
    J Biol Chem; 2002 Feb; 277(6):4413-21. PubMed ID: 11704664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal transfer protein (MTP) inhibition-a novel approach to the treatment of homozygous hypercholesterolemia.
    Sirtori CR; Pavanello C; Bertolini S
    Ann Med; 2014 Nov; 46(7):464-74. PubMed ID: 24987866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.
    Lettéron P; Sutton A; Mansouri A; Fromenty B; Pessayre D
    Hepatology; 2003 Jul; 38(1):133-40. PubMed ID: 12829995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly.
    Gordon DA; Jamil H
    Biochim Biophys Acta; 2000 Jun; 1486(1):72-83. PubMed ID: 10856714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased secretion of ApoB follows inhibition of ApoB-MTP binding by a novel antagonist.
    Bakillah A; Nayak N; Saxena U; Medford RM; Hussain MM
    Biochemistry; 2000 Apr; 39(16):4892-9. PubMed ID: 10769147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
    Tenenbaum A; Fisman EZ; Motro M; Adler Y
    Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary aspects of the biology and therapeutic regulation of the microsomal triglyceride transfer protein.
    Hooper AJ; Burnett JR; Watts GF
    Circ Res; 2015 Jan; 116(1):193-205. PubMed ID: 25552696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapies for dyslipidemia: known knowns and known unknowns of MTP inhibitors.
    Raval SK; Raval PS; Jain MR
    Recent Pat Endocr Metab Immune Drug Discov; 2012 Jan; 6(1):24-9. PubMed ID: 22216777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.